George Kumar: ASCO's position statement regarding AI usage

George KumarAstrazeneca's senior director of Medical Diagnostics, PAN Tumors and GI Cancer, shared a LinkedIn post.

“ASCO and AI in oncology: rooted in human-centered care.

A good problem to read.

Boundary setting: ASCO position statement regarding AI usage.

The statement outlines the following six principles:

1. Transparency: AI tools and applications must be transparent throughout their lifecycle.
2. Informational Stakeholders: Patients and clinicians should be aware when AI is used in clinical decision-making and patient care.
3. Fairness: AI developers and users must protect against bias in the design of AI models and ensure that applications use access to AI tools.
4. Accountability: AI systems must comply with legal, regulatory, and ethical requirements governing the use of data. AI developers must be responsible for their compliance with AI systems, decisions, and legal, regulatory, and ethical standards.
5. Monitoring and privacy: Decision makers need to establish institutional compliance policies governing AI use. This includes protections that protect the autonomy of the clinician and patient decisions and privacy of individual health information.
6. Human-centered applications: Human interaction is a fundamental component of healthcare delivery. AI does not rule out the need for human interactions, and should not be used as an alternative to sensitive interactions that require them.

Courtesy: 2025 American Society of Clinical Oncology (ASCO). ”

read more.

Detailed post George Kumar On OnCodaily.